The Long-term Clinical Results of a Platelet Glycoprotein IIb/IIIa Receptor Blocker (Abciximab: ReoPro®) Coated Stent in Patients with Coronary Artery Disease

摘要

Background :Previously, the inhibition of coronary restenosis with Abciximab (ReoPro^®)-coated stent in a porcine model was reported. ReoPro^® inhibits platelet aggregation, the proliferation of vascular smooth muscle cells and the inflammatory reaction.